全球佐剂法规：2026 年及以后的战略展望
2026年八月20日 Adjuvants have long been described as inert ingredients, but that characterization is increasingly misaligned with regulatory reality. As pesticide policy evolves globally, regulators are paying closer attention to how adjuvants influence spray behavior, environmental exposure, product efficacy, and downstream risk considerations. For manufacturers, formulators, and registrants, the implication is clear: Adjuvants are shifting from a peripheral consideration to a strategically significant regulatory component.
What is changing is not only perception, but also assessment. Authorities are increasingly examining whether products reduce spray drift, enhance deposition, modify uptake kinetics, or contribute to persistence and environmental loading. This functional lens is driving greater demand for transparency, more robust performance data, and closer alignment with broader chemical policy frameworks.
A Fragmented but Evolving Global Landscape
Despite increasing scrutiny, adjuvant regulation remains fragmented across jurisdictions. In the U.S., there is no unified federal registration system for pesticide adjuvants comparable to that for active ingredients. Oversight is distributed between federal and state levels, with several states requiring registration or notification, while federal frameworks remain relevant for labeling, residues, and risk assessment. Recent U.S. Environmental Protection Agency (EPA) insecticide risk mitigation strategies have also increased attention to application conditions and drift reduction measures, indirectly elevating the relevance of certain adjuvant functions in stewardship discussions.
In the EU, adjuvants and formulation-related substances are governed through overlapping frameworks rather than a single harmonized regime, primarily under Regulation (EC) No. 1107/2009 and the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) Regulation (EC) No. 1907/2006. The EU Chemicals Strategy for Sustainability (CSS) is further reshaping regulatory direction, including the ongoing development of the “One Substance, One Assessment (OSOA)” approach. While still in phased implementation and not yet a fully integrated legal system, OSOA is already strengthening coordination between agencies such as the European Food Safety Authority and European Chemicals Agency, with increasing convergence in hazard and risk assessment methodologies across regulatory domains.
Australia represents a more centralized model, with the Australian Pesticides and Veterinary Medicines Authority responsible for product registration, supported by state-level enforcement mechanisms. Across Asia-Pacific, regulatory systems remain heterogeneous, although the general trajectory is toward stronger chemical governance, improved disclosure requirements, and gradual alignment with OECD-based principles.
U.S.: Increasing Emphasis on Function and Evidence
In the U.S., regulatory emphasis is increasingly shaped by EPA risk mitigation frameworks rather than adjuvant-specific regulation. EPA’s recent insecticide risk management approaches place greater focus on reducing off-target exposure, including drift reduction, buffer zones, and application practices.
Within this context, adjuvants — particularly drift reduction and deposition-enhancing products — are gaining indirect relevance as part of integrated risk management strategies. However, there is still no formal federal classification of adjuvants as mitigation tools.
For the industry, the implication is clear: Functional claims must be evidence based. Statements relating to drift reduction, spray quality improvement, deposition efficiency, or environmental benefits require credible and reproducible supporting data. In an increasingly risk-driven regulatory environment, marketing claims alone are insufficient without technical substantiation.
Europe: Co-Formulants and Chemical Policy Convergence
The EU is steadily tightening its regulatory oversight of formulation components used in plant protection products, with growing attention on co-formulants and other nonactive substances. Rather than operating under a single dedicated regime, these materials are governed through an interlocking framework that includes Regulation (EC) No. 1107/2009 on plant protection products and the REACH Regulation (EC) No. 1907/2006 on industrial chemicals, supported by classification and labeling rules under the Classification, Labeling, and Packaging (CLP) Regulation (EC) No. 1272/2008.
A central driver of current policy development is the EU CSS, which is reshaping how chemical safety is assessed across sectors. A key element of this strategy is the OSOA initiative.
Within the plant protection product regime, co-formulants are receiving increased regulatory attention, particularly where human health or environmental concerns are identified. Although Regulation (EC) No. 1107/2009 does not establish a fully harmonized EU-wide positive list of permitted co-formulants, member states are required to ensure that co-formulants used in authorized products do not give rise to unacceptable effects on human or animal health or the environment. In parallel, substances classified as carcinogenic, mutagenic, or toxic for reproduction, or identified as persistent, bioaccumulative, and toxic (PBT/vPvB), are increasingly subject to restriction pressure or substitution expectations under REACH-driven regulatory processes.
This trend is reinforced by broader EU chemical governance tools, including the identification of substances of very high concern under REACH and restrictions under both REACH and the Persistent Organic Pollutants Regulation. Together, these mechanisms are contributing to a more preventive, hazard-driven approach to chemical acceptability, including substances used in formulation and adjuvant systems.
In practice, this is pushing chemical regulation away from siloed assessments toward a more integrated approach. In practice, adjuvants, co-formulants, and formulation aids are increasingly assessed through converging hazard criteria, regardless of their functional role in the final product. At the same time, increasing policy attention on persistent chemistries, including per- and polyfluoroalkyl substances (PFAS), is adding further pressure on formulation choices, even where full regulatory restrictions are still under development.
For the industry, the implications are material. Formulation decisions are increasingly shaped not only by pesticide-specific legislation but also by upstream chemical controls under REACH and downstream classification and labeling requirements under CLP. As a result, substances with high-concern properties — particularly those associated with persistence, bioaccumulation, or toxicity — face growing substitution pressure, even where technical performance benefits remain significant.
Overall, the EU is clearly moving in a more precaution-driven direction, and that trend is likely to continue. This convergence is expected to continue, reinforcing the importance of early regulatory foresight, cross-regime compliance planning, and proactive portfolio adaptation by industry stakeholders.
PFAS and the Challenge of Persistent Chemistry
A central theme in current regulatory developments is the scrutiny of persistent chemicals, particularly PFAS. These chemistries have historically provided strong performance benefits in adjuvant applications, particularly in wetting and spreading functions. However, their persistence, mobility, and bioaccumulation potential have placed them under increasing regulatory scrutiny.
Across jurisdictions, policy direction is moving toward restriction or phase out of high-persistence substances, including proposed broad PFAS restrictions under REACH in the EU. Even where full bans are not yet implemented, regulatory uncertainty and reputational risk are increasing.
For manufacturers, this creates a dual pressure: Portfolios based on fluorinated chemistries face tightening constraints, while demand is accelerating for nonfluorinated, biodegradable alternatives that can deliver comparable performance.
Asia-Pacific: Convergence without Uniformity
The Asia-Pacific region remains highly diverse in regulatory approaches, though gradual convergence is underway. Countries are strengthening classification systems, improving labeling requirements, and formalizing registration pathways for agricultural inputs, including adjuvants.
In the Philippines, agricultural adjuvants are regulated under the Fertilizer and Pesticide Authority framework and typically require registration prior to commercialization, placing them within a defined regulatory control system. Thailand, by contrast, does not regulate adjuvants under its primary agricultural chemical registration system but instead treats them as label-controlled products under consumer protection laws. This creates a different compliance focus, centered on accurate and non-misleading product information.
This regulatory diversity presents a key challenge for multinational companies, requiring market-specific compliance strategies and flexible product positioning. A uniform global approach is increasingly difficult without tailored regulatory planning and adaptive formulation design.
Strategic Priorities for the Industry
Three priorities stand out. First, companies need to invest more in data generation. In particular, demonstrating clear functional benefits, especially those linked to risk mitigation, will be increasingly important for both regulatory acceptance and market positioning.
Second, portfolio review is becoming more urgent. Substances with persistence concerns or other high-hazard properties should be assessed for their longer-term regulatory viability. In many cases, earlier reformulation can help reduce future compliance risks and also create a competitive advantage.
Third, regulatory foresight is becoming a core capability. The EU continues to set the pace in chemical policy, and its direction often shapes expectations in other regions as well. Companies that follow these developments early will be in a better position than those reacting after regulatory changes are already in motion.
More broadly, adjuvants are no longer just formulation aids. They are increasingly part of the wider regulatory discussion around pesticide performance, exposure, and risk management. This means companies will need to connect efficacy, safety, and regulatory positioning more closely than before if they want to stay ahead in this space.
在 AgriBusiness Global 上阅读更多类似文章 2026年佐剂深度解析.
立即获取时事通讯！
